Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Cancer Vaccines - Global Market Outlook (2016-2022)

Stratistics Market Research Consulting
Posted on: 18 Oct 16

According to Stratistics MRC, Global Cancer Vaccines market is accounted for $2.25 billion in 2015 and is expected to reach $10.00 billion by 2022 growing at a CAGR of 23.7%. Factors such as rising number of cancer patients, increasing ageing population and awareness of vaccines are fueling the market. However, less availability of vaccines and advanced treatments in underdeveloped regions may limit the market growth. North America accounted for the largest share in the market followed by Asia Pacific. The favourable growth is attributed to supportive government and other organisations such as World health organisation and GAVI initiatives.

Some of the key players in Global Cancer Vaccines market include Oxford BioMedica, Vaccinogen Inc., GlaxoSmithKline, Sanofi India Limited-P.P. Enterprises, Juvaris Biotherapeutics, Merk&co, Prima BioMed Ltd, Cytos Biotechnology AG, Ubivac, duro BioTech, AstraZeneca plc., and MedImmune, LLC.

Disease Indication Covered:
• Cervical cancer
• Esophageal cancer
• Liver cancer
• Prostate cancer
• Lung cancer
• Breast cancer
• Stomach cancer

Technologies Covered:
• Inactivated Vaccines     
• Peptide/protein vaccines
• Synthetic Vaccines                                                             
• Toxoid Vaccines                                                  
• Live Attenuated Vaccines                                                                
• Recombinant Vector Vaccines                                                      
• Antigen vaccines
• Dendritic Cell Vaccines                                                      
• Subunit Vaccines                                                                
• Heat shock protein vaccines
• DNA- and vector-based vaccines
• Conjugate Vaccines                                                           
• Anti-idiotype vaccines
• Cancer stem cell vaccines                                                 

End Users Covered:
• Adults                                                     
• Paediatrics       
                                       
Vaccine Types Covered:
• Therapeutic Vaccines                                                        
• Preventive Vaccines                                                           

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Editor's Details

James Lamb
Research and Marketing
www.strategymrc.com
3012025929
info@strategymrc.com

Last updated on: 18/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.